Download Document

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Investment management wikipedia , lookup

Transcript
Medicines Management
Achievements in the last 12 months
Prescribing
• Agreed formal service specifications with providers.
• Maintained and enhanced communication with Thurrock CCG prescribers in
order to drive the prescribing agenda and promote high quality, safe, evidencebased and cost effective prescribing.
• Achieved a high level of local engagement with ScriptSwitch (a new prescribing
system) which delivered savings significantly higher than the national average.
Primary Care
• Diabetes and Respiratory Networks have agreed health economy-wide policies
for high impact Primary Care drugs.
• Updated guidelines around Oral Nutritional Supplements and produced
significant savings around Home Enteral Feeding.
• Achieved the targets for Medicines Management QIPP for 2014/15.
Acute Trust
• Worked closely with Basildon Hospital to update the local Primary Care guidance
for antibiotic prescribing.
• Supported the development of new, more efficient pathways for Deep Vein
Thrombosis and Atrial Fibrillation.
Community
• Worked closely with providers to develop a wound-care formulary which is due
to be launched in south west Essex in September 2015.
• Worked closely with providers to develop and launch an End of Life Formulary.
Medicines Management
Commissioning Intentions/Forward Plans
• Development and/or update of formulary for other high impact areas such as insulins, emollients etc.
• Develop and implement a strategy for antibiotics in line with national recommendations to reduce antimicrobial
resistance.
• Scope transformation projects for stoma products and incontinence products as part of the QIPP agenda.
• Review processes for Basildon Hospital Medicines Management Committee and CCG Medicines and Safety
Group.
• Ensure delivery of High Cost drug challenges with acute trust.
• When reviewing service specifications, or formulating new medicines etc ensure financial implications and clinical
responsibilities are considered.